Login to Your Account

The Search for Venture Capital Continues to be Challenging

By Peter Winter

Monday, April 8, 2013

The environment for raising private capital continues to be challenging and, as a result, there has been a dramatic slowdown in the number of deals that have successfully been concluded. Worldwide, according to BioWorld Snapshots, private biotech companies developing therapeutics raised $403.5M in VC dollars in the first quarter of 2013, down a whopping 48 percent from the $775 million raised in the same period last year.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription